ProPhase Labs, Inc.: Form 10-K for the period ended Dec 31, 2019
Filed with the SEC on Mar 26, 2020 and accepted by EDGAR at Mar 26, 2020, 20:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-01-01 to 2019-12-31 | $9.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $7.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2019-01-01 to 2019-12-31 | $2.6m | us-gaap:GrossProfit |
| Research and development | 12 months2019-01-01 to 2019-12-31 | $332.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2019-01-01 to 2019-12-31 | −$3.2m | us-gaap:OperatingIncomeLoss |
| Net income | 12 months2019-01-01 to 2019-12-31 | −$3.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | −$0.27 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | −$841.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $228.0k | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months2019-01-01 to 2019-12-31 | $5.8m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2019-12-31 | $434.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $9.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $12.3m | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $933.0k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $1.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-12-31 | $11.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-20-004807. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.